| Date Filed | Type | Description |
| 08/04/2023 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 300 shares
@ $181.08, valued at
$54.3k
Sold 500 shares
@ $182.45, valued at
$91.2k
Sold 560 shares
@ $183.75, valued at
$102.9k
Sold 1,535 shares
@ $184.89, valued at
$283.8k
Sold 1,714 shares
@ $185.99, valued at
$318.8k
Sold 1,389 shares
@ $187.04, valued at
$259.8k
Sold 450 shares
@ $187.71, valued at
$84.5k
Exercised 22,477 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 3,454 options to buy
@ $189.87, valued at
$655.8k
|
|
| 08/03/2021 |
4
| BONNEY MICHAEL W (Executive Chair) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 22,477 restricted stock units
@ $0 |
|
| 07/19/2021 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 4,032 options to buy
@ $171.95, valued at
$693.3k
|
|
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 15,000 options to buy
@ $7.44, valued at
$111.6k
Granted 15,000 options to buy
@ $0 |
|
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on BRISTOL MYERS SQUIBB CO|
Txns:
| Exercised 903 restricted stock units
@ $0
Exercised 558 restricted stock units
@ $0 |
|
| 06/09/2020 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on BRISTOL MYERS SQUIBB CO|
Txns:
| Bought 88 shares
@ $58.9, valued at
$5.2k
|
|
| 06/09/2020 |
3/A
| BONNEY MICHAEL W (Director) has filed a Form 3/A on BRISTOL MYERS SQUIBB CO |
| 06/09/2020 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 18,188 options to buy
@ $9.99, valued at
$181.7k
|
|
| 06/05/2020 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on BRISTOL MYERS SQUIBB CO|
Txns:
| Exercised 2,949 restricted stock units
@ $0 |
|
| 04/02/2020 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on BRISTOL MYERS SQUIBB CO|
Txns:
| Granted 414 restricted stock units
@ $55.74, valued at
$23.1k
|
|
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on BRISTOL MYERS SQUIBB CO|
Txns:
| Granted 3,018 restricted stock units
@ $62.95, valued at
$190k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/27/2019 |
3
| BONNEY MICHAEL W (Director) has filed a Form 3 on BRISTOL MYERS SQUIBB CO |
| 11/27/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 11/22/2019 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on BRISTOL MYERS SQUIBB CO|
Txns:
| Granted 656 restricted stock units
@ $56.41, valued at
$37k
|
|
| 11/22/2019 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Disposed/sold 2,209 shares
@ $0
Disposed/sold 2,000 shares
@ $0
Disposed/sold 10,000 options to buy
@ $115.78, valued at
$1.2M
Disposed/sold 10,000 options to buy
@ $112.16, valued at
$1.1M
Disposed/sold 11,000 options to buy
@ $99.98, valued at
$1.1M
Disposed/sold 10,500 options to buy
@ $121.04, valued at
$1.3M
Disposed/sold 13,266 options to buy
@ $77.38, valued at
$1M
Disposed/sold 300 restricted stock units
@ $0
Disposed/sold 970 restricted stock units
@ $0
Disposed/sold 4,756 restricted stock units
@ $0
Disposed/sold 1,000 restricted stock units
@ $0 |
|
| 09/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,000 options to buy
@ $72.01, valued at
$648.1k
|
|
| 06/17/2019 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on CELGENE CORP /DE/|
Txns:
| Exercised 484 restricted stock units
@ $0
Exercised 300 restricted stock units
@ $0
Exercised 375 restricted stock units
@ $0 |
|
| 06/12/2019 |
4
| BONNEY MICHAEL W (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 11,000 options to buy
@ $5.6, valued at
$61.6k
|
|
|